Since in BRAF wild-type thyroid cancer cells (TPC-1) and control cells (Nthy-ori3-1) exposure to 5 mM vitamin C did not affect ROS perturbations and exhibited low sensitivity to cytotoxic effect, the analysis of metabolic profiles was restricted to B-CPAP and K1 cells. This evidence concerns the gene BRAF and thyroid gland carcinoma.